Regeneration Technologies Added to Russell 2000 Index

Regeneration Technologies, Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic and other biologic implants, today announced it has been added to the Russell 3000® Index and Russell 2000® Index on June 22, 2007, when the Russell Investment Group reconstituted its comprehensive set of U.S. and global equity indexes. "We believe our inclusion in the Russell 3000 Index and the Russell 2000 Index is an additional example of the results of our hard work and successes in the past six months,” said Brian K. Hutchison, RTI’s chairman, president and chief executive officer. The annual reconstitution of the Russell 3000 captures the 3,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization. The largest 1,000 companies in this ranking comprise the Russell 1000 and the next 2,000 companies become the Russell 2000. Russell indexes are widely used by investment managers and institutional investors for both index funds and as benchmarks for passive and active investment strategies. About Regeneration Technologies, Inc. RTI processes allograft and xenograft tissue into shaped implants for use in orthopedic and other surgeries with a commitment to science, safety and innovation. RTI also holds the patents on BioCleanse®, the only proven tissue sterilization process validated to eliminate viruses, bacteria, fungi and spores from tissue without impacting the structural or biomechanical integrity of the tissue. The company has distributed more than half a million allograft implants sterilized with the BioCleanse process with zero incidence of infection. RTI is accredited by the American Association of Tissue Banks. Except for historical information, any statements made in this press release about the company's anticipated financial results, growth rates, new product introductions, future operational improvements and results, regulatory approvals or changes to the company's agreements with its distributors are forward-looking statements subject to risks and uncertainties, such as those described in the company's public filings on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results reflected in these forward-looking statements. Copies of the company's SEC filings may be obtained by contacting the company or the SEC or by visiting RTI's Web site at www.rtix.com or the SEC's Web site at www.sec.gov.